Literature DB >> 19744750

Plasma citrulline is a marker of absorptive small bowel length in patients with transient enterostomy and acute intestinal failure.

Denis Picot1, Laurence Garin, Florence Trivin, Michel P Kossovsky, Dominique Darmaun, Ronan Thibault.   

Abstract

BACKGROUND & AIMS: Small bowel disruption is often complicated by acute intestinal failure and can be corrected by chyme reinfusion (CR). Plasma citrulline ([Cit]) is a biomarker of the enterocyte mass. Our aim was to determine whether [Cit] could be a marker of absorptive intestinal mass or function by assessing whether CR could affect intestinal absorptive function and [Cit].
METHODS: Twenty-six patients with small bowel disruption and double enterostomy were treated with CR. Fecal wet weight, nitrogen and fat absorption, parenteral nutrition delivery and [Cit] were measured before and after the initiation of CR with a median follow-up of 30 days.
RESULTS: CR decreased the intestinal wet weight output (median+/-IQ, 2384+/-969 vs. 216+/-242mLd(-1), P<0.0001) and parenteral nutrition dependence (65% vs. 8%, P<0.01). CR was associated with a rise in net nitrogen and fat digestive absorption and [Cit] (17.0+/-10.0 vs. 31.0+/-12.0micromolL(-1), P=0.0001). Before the initiation of CR, [Cit] correlated positively with the absorptive post-duodenal small bowel length (r=0.39, P=0.04), but not with the total post-duodenal small bowel length (r=0.11, P=0.60).
CONCLUSION: CR allows for a dramatic improvement of intestinal absorptive function and a near doubling in [Cit] level. [Cit] is not a marker of overall intestinal mass, but of the absorptive small bowel function. Copyright 2009 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19744750     DOI: 10.1016/j.clnu.2009.08.010

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  5 in total

1.  Associations between intestinal mucosal function and changes in plasma zinc concentration following zinc supplementation.

Authors:  K Ryan Wessells; Sonja Y Hess; Noel Rouamba; Zinewendé P Ouédraogo; Mark Kellogg; Rie Goto; Christopher Duggan; Jean-Bosco Ouédraogo; Kenneth H Brown
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-09       Impact factor: 2.839

2.  Distal Bowel Re-feeding in Patients with Proximal Jejunostomy.

Authors:  Anand Nagar; Siddharth Mehrotra; Amitabh Yadav; Vivek Mangla; Shailendra Lalwani; Naimish Mehta; Samiran Nundy
Journal:  J Gastrointest Surg       Date:  2018-05-18       Impact factor: 3.452

3.  Determining optimal therapy of dogs with chronic enteropathy by measurement of serum citrulline.

Authors:  Magda Gerou-Ferriani; Rhiannon Allen; Peter-John M Noble; Alexander J German; Marco Caldin; Daniel J Batchelor
Journal:  J Vet Intern Med       Date:  2018-04-16       Impact factor: 3.333

Review 4.  Citrulline as a marker of intestinal function and absorption in clinical settings: A systematic review and meta-analysis.

Authors:  Konstantinos C Fragkos; Alastair Forbes
Journal:  United European Gastroenterol J       Date:  2017-10-12       Impact factor: 4.623

5.  Chyme Reinfusion Restores the Regulatory Bile Salt-FGF19 Axis in Patients With Intestinal Failure.

Authors:  Kiran V K Koelfat; Denis Picot; Xinwei Chang; Ronan Thibault; Frank G Schaap; Steven W M Olde Damink; Mireille Desille-Dugast; Hans M van Eijk; Sander M J van Kuijk; Martin Lenicek; Sabrina Layec; Marie Carsin; Laurence Dussaulx; Eloi Seynhaeve; Florence Trivin; Laurence Lacaze
Journal:  Hepatology       Date:  2021-08-26       Impact factor: 17.425

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.